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Background: The increasing interest in probiotic lactobacilli in health maintenance has raised the question of
potential risks. One possible side effect could be an increased acidogenicity in dental plaque. The aim of this study
was to investigate the effect of probiotic lactobacilli on plaque lactic acid (LA) production in vitro and in vivo.
Methods: In the first part (A), suspensions of two lactobacilli strains (L. reuteri DSM 17938, L. plantarum 299v) were
added to suspensions of supragingival dental plaque collected from healthy young adults (n=25). LA production
after fermentation with either xylitol or fructose was analyzed. In the second part (B), subjects (n=18) were given
lozenges with probiotic lactobacilli (L. reuteri DSM 17938 and ATCC PTA 5289) or placebo for two weeks in a
double-blinded, randomized cross-over trial. The concentration of LA in supragingival plaque samples was
determined at baseline and after 2 weeks. Salivary counts of mutans streptococci (MS) and lactobacilli were
estimated with chair-side methods.
Results: Plaque suspensions with L. reuteri DSM 17938 produced significantly less LA compared with L. plantarum
299v or controls (p<0.05). Fructose gave higher LA concentrations than xylitol. In part B, there were no significant
differences in LA production between baseline and follow up in any of the groups and no differences between test
and placebo were displayed. The salivary MS counts were not significantly altered during the intervention but the
lactobacilli counts increased significantly in the test group (p<0.05).
Conclusion: Lactic acid production in suspensions of plaque and probiotic lactobacilli was strain-dependant and
the present study provides no evidence of an increase in plaque acidity by the supply of selected probiotic
lactobacilli when challenged by fructose or xylitol. The study protocol was approved by The Danish National
Committee on Biomedical Research Ethics (protocol no H-2-2010-112).
Trial registration: NCT01700712Background
Probiotic bacteria have long been used for improving
gastro-intestinal health [1] and there is emerging evi-
dence that lactobacilli-derived probiotic bacteria also can
have beneficial influences on oral health. Several studies
have shown a decrease in oral mutans streptococci
counts after short-term consumption of L. reuteri [2-5]
and L. rhamnosus [6] and a few have demonstrated an ef-
fect on caries prevention and control [7-9]. However, less
attention has been paid to the potential risk of probiotic
usage. Lactobacilli are considered a part of the resident
oral microflora but elevated counts have been reported* Correspondence: mke@sund.ku.dk
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distribution, and reproduction in any mediumafter probiotic regimes [10]. Lactobacilli are highly acido-
genic and aciduric but mainly found in the deep carious
lesions [11] and hence, not considered to be involved in
the initiation of caries lesion. The ability of probiotic lacto-
bacilli to ferment sugars has been shown to be dependent
on the type of sugars and to vary between different strains
in vitro [12]. For example, strains of L. plantarum pro-
duced acids at a rapid rate while L. reuteri slowly generated
weak reactions with glucose, lactose, sucrose, maltose and
melibiose under both aerobic and anaerobic conditions
[12]. However, the clinical relevance of such findings is
sparsely investigated. Recently, Marttinen and co-workers
[13] reported that intake of tablets containing either L.
rhamnosus GG or L. reuteri did not seem to affect the lac-
tic acid levels in dental plaque. With addition of probiotic
bacteria to many commercially available products and theirCentral Ltd. This is an Open Access article distributed under the terms of the
/creativecommons.org/licenses/by/2.0), which permits unrestricted use,
, provided the original work is properly cited.
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intended for oral use are important. Our aim was therefore
to investigate the effect of probiotic lactobacilli on lactic
acid production in supragingival dental plaque in vitro as
well as in vivo. The null hypothesis was that the acidogeni-
city would not differ from placebo or controls.
Methods
The investigation was conducted in two parts; a laboratory
study and a double-blinded, randomized cross-over trial.
For the clinical part, a power calculation (α=0.05 and
β=0.20) based on pilot findings indicated that 18 subjects
were needed in the test and placebo groups respectively.
The probiotic strains used in both parts are all commer-
cially available and used in fruit drinks and in tablets. The
study protocol was approved by The Danish National
Committee on Biomedical Research Ethics (protocol no
H-2-2010-112). Clinical trial number NCT01700712.
Part A
Twenty-five healthy young adults of both sexes (mean age
27 yrs) with uncompromised oral health (mean DMFT
(Decayed, Missed, Filled Teeth) = 4) were enrolled after
informed consent. None of the subjects were habitual con-
sumers of probiotic products. They were instructed to re-
frain from tooth brushing for 24 hours before their visit.
Supragingival dental plaque was collected from all teeth
with a blunt explorer, pooled and transferred to a plastic
tube. The fresh samples was suspended and homogenized
in PBS (Phosphate buffered saline) (pH=7.2) and adjusted
to an optical density of OD=0.2 at 340 nm. Five hundred
μl of the plaque suspensions were thereafter mixed with
500 μl of equally dense suspensions of either L. reuteri
DSM 17938 (Biogaia, Stockholm, Sweden) or L. plantarum
299v (Probi AB, Lund, Sweden) in PBS. The lactobacilli
strains were cultivated in Man Rogosa Sharpe (MRS) broth
(Oxoid Ldt., Basingstoke, Hampshire, UK) in an anaerobic
incubator at 37°C for 24 h and then washed twice in PBS.
One ml of the plaque suspension with no addition of
probiotic bacteria served as control. Also, one ml sus-
pensions of lactobacilli with the same optical density as
the other samples were used as controls. Baseline spec-
trophotometric (Genesys 10 uv Scanning, Thermo Sci-
entific, MA, USA) values were recorded and the
suspensions were then incubated for 1h in 37°C without
agitation. The OD-readings were repeated and the acid
production was initiated by adding 25 μl fructose (10%)
or xylitol (10%) to each sample. After 30 minutes of fur-
ther incubation, the fermentation was stopped by cen-
trifugation for 2 min (10,000 rpm) and the supernatant
was withdrawn for further analyses. The concentration
of the L- and D- isomers of lactic acid (LA) was deter-
mined enzymatically and expressed as μg/ml with aid of
a commercial kit (EnzyPlus, Biocontrol) according tothe manufacturer’s instructions. All assays were per-
formed in duplicate and the mean sum of the L- and D-
isomers were calculated.
Part B
Thirty subjects were screened for the presence of saliv-
ary mutans streptococci and eighteen were eligible for
the clinical trial (14 female, 4 male; mean age = 26 yr;
DMFT= 2). The inclusion criteria were i) moderate to
high counts of salivary mutans streptococci (>104 CFU)
as estimated with the Dentocult SM chair-side test, ii)
no visible open caries lesions or periodontal disease, and
iii) being non-smokers. Also, none of the subjects were
consuming probiotic products, or had been taking anti-
biotics within the last two months. After group alloca-
tion and a run-in period of 3 days (phase 1) with
professional tooth cleaning, the participants were
instructed to take three tablets per day (morning, noon
and evening) containing either two strains of the pro-
biotic bacterium L. reuteri (DSM 17938 and ATCC PTA
5289; 1x108 CFU of each strain) or placebo for 2 weeks
(phase 2). Both tablets were provided by BioGaia AB
(Sweden). Stimulated saliva samples were collected after
3 minutes of chewing paraffin gums. Pooled supragingi-
val plaque samples were collected at baseline and after
the intervention. Numbers of mutans streptococci and
Lactobacilli in saliva was determined by the aid of a test
kit (Dentocult SM Strip Mutans and Dentocult LB re-
spectively, Orion Diagnostica, Finland) according to the
manufacturer’s guidelines. The samples were all col-
lected between 10 and 11 am before lunch and approxi-
mately 3–4 hours after consuming the last tablet. After a
3-week washout period (phase 3), the 2-week interven-
tion was repeated with the second tablet (phase 4).
Again, baseline and follow-up samples were collected.
The tablets were supplied and coded A or B by the
manufacturer and the test and placebo products were
identical in taste, composition and appearance. The code
was not unveiled until after the analyses and the statis-
tical calculations. During all phases, the subjects were
asked to maintain their normal oral hygiene routines in-
cluding tooth brushing with fluoride toothpaste. They
were however firmly requested to avoid intake of any
food items supplemented with probiotic bacteria.
Laboratory assays
All analysis and bacterial counts were made without
knowledge of group allocation. The salivary samples were
incubated in 2 and 4 days respectively at 37°C for the pres-
ence of mutans streptococci and lactobacilli with aid of
selective chair-side tests (Dentocult SM and LB, respect-
ively; Orion Diagnostica, Helsinki, Finland) according
to the manufacturer’s instructions. The colony forming
units were counted in a stereomicroscope (12–25 x
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egories as described in Tables 1 and 2. The concentration
of LA in the plaque samples was determined in duplicate
as described above using the fresh plaque samples.
Statistical methods
Data was processed with the IBM-SPSS software (version
19.0, Chicago Ill, USA). In part A, differences in out-
come between probiotic strains vs. control was analyzed
with Wilcoxon sign rank test. In part B, acid production
was compared before and after intervention within
groups as well as between the groups before and after
intervention by Wilcoxon signed rank test. Differences
in lactobacilli and mutans streptococci were analyzed by
Chi square test. A p value <0.05 was considered statisti-
cally significant. Reliability of the bacterial scoring was
analyzed on a random sample (20%) of the tests and the
intra examiner correlation showed an ICC value of 0.97.
Results
Part A
All plaque samples from the 25 subjects produced de-
tectable levels of lactic acid and the levels initiated from
fructose were significantly higher than those from xylitol
(Figure 1). However, considerable inter-individual varia-
tions were noted. After fermentation with fructose, the
plaque suspensions mixed with L. reuteri DSM 17938
produced significantly less LA compared with both the
control samples and the samples with L. plantarum
299v (p<0.05). There were no statistical significant differ-
ences between the control samples and the samples with
L. plantarum 299v. The control suspensions containing
only one of the two lactobacilli both showed acid
production of the same magnitude as the plaque control
(L. reuteri DSM 17938: mean 6.0 (4.8) and L. plantarum
299v: mean 9.3 (5.9)). After acid production initiated
with xylitol, a statistically significant (p<0.035) difference
between the control sample and the samples with L.
reuteri DSM 17938 was obtained. However, no signifi-
cant differences between the control samples and the
samples with L. plantarum 299v or between the two
samples with added probiotic lactobacilli were seen. The
samples where xylitol was added to pure suspensions of
either of the lactobacilli both showed slightly lowerTable 1 Salivary lactobacilli score
Lactoba
0 (0 CFU/ml) 1 (103 CFU/ml)
Test BL 9 4
Test FU 0 4
Placebo BL 7 5
Placebo FU 5 6
Samples collected from subjects (n=18) before (BL) and after (FU) a 2-week intervenvalues than the plaque suspension, but did not differ sig-
nificantly (L. reuteri DSM 17938: mean 0.5 ( 3.4) and L.
plantarum 299v: mean 3.4 (3.5)).
Part B
There were no major differences in LA concentration
between the samples collected at baseline and follow up
in either the test or the placebo group (Table 3). Again,
the samples supplied with fructose as a substrate dis-
played significantly higher levels of produced lactic acid
than those with added xylitol. The salivary lactobacilli
scores in the test group increased significantly (p<0.05)
from baseline to follow-up but no differences were seen
in the placebo group (Table 1). At baseline, nine partici-
pants in the test group presented non-detectable levels
of lactobacilli versus six in the placebo group. After two
weeks, all subjects in the test group displayed detectable
counts while five subjects in the placebo group still had
levels beyond detection. In Table 2, the salivary mutans
scores are presented. No statistically significant effects
were observed during the experimental periods in any of
the groups. No side effects following the use of the pro-
biotic lozenges were reported.
Discussion
The increased interest in using of probiotic lactobacilli
to improve oral health has raised concerns on its pos-
sible side effects. One side effect from a cariological
point of view would be an increased production of or-
ganic acids in the dental plaque. Therefore, we wanted
to investigate if addition of probiotic lactobacilli to den-
tal plaque would influence its acidogenicity. In the la-
boratory part, we found clear differences between the
lactic acid production in suspensions of pooled plaque
and L. reuteri DSM 17938 on one hand and plaque plus
L. plantarum 299v or pure controls on the other. This
was in agreement with the in vitro study of Hedberg
et al. [12], who found L. plantarum 299v to be most
prone to produce acid among six different commercial
strains tested. Conversely, Haukioja and co-workers [14]
found that both L. reuteri DSM (formerly ATCC 55730)
and L. plantarum 299v lowered the pH significantly after
fermentation of glucose and sucrose. According to
Hedberg et al. [12], the fermentation of sucrose andcilli score
2 (104 CFU/ml) 3(>105 CFU/ml) p




tion period with L. reuteri or placebo. NS = not significant.
Table 2 Mutans streptococci score
Streptococcus mutans score
0 (<103CFU/ml) 1 (103<104 CFU/ml) 2 (104<105CFU/ml) 3 (≥105CFU/ml) p
Test BL 2 4 8 4 NS
Test FU 1 7 6 4
Placebo BL 2 5 6 5 NS
Placebo FU 1 4 9 4
Samples collected from subjects (n=18) before (BL) and after (FU) a 2-week intervention period with L. reuteri or placebo. NS = not significant.
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the pH (pH 5.2-6.8), whereas the fermentation of fruc-
tose caused a minor increase in pH (pH>6.8). This, to-
gether with our present results, indicates that the sugar
chosen for fermentation has a strong impact on the LA
production of L. reuteri. Thus, from the first part of this
study, it seems clear that the acidogenicity of suspen-
sions of dental plaque and probiotic bacteria is strain-
dependant and highly influenced by the type of sugar
available. Moreover, it was noteworthy that the results of
part A were completely in line with findings of previous
in vitro studies [12,14]. This indicates that the laboratory
methods for screening probiotic candidates for oral dis-
eases may be useful to differentiate between wanted and
unwanted targeted properties. As acid production in sus-
pensions in the laboratory may not mimic the exact con-
ditions in of the complex biofilm in situ, a step further
could be to study the pH of the plaque in vivo by a
micro pH-meter.
In the clinical part of this study we found no differ-
ences in acid production before and after the interven-
tion with L. reuteri or placebo when the plaque samplesFigure 1 Mean lactic acid production in plaque suspensions and with
fermentation of fructose (a) and xylitol (b). The controls are plaque susp
30 min fermentation. ns = not significant.were fermenting fructose. Thus, the null hypothesis
could not be rejected. The findings were in accordance
with Marttinen et al. [13], who failed to demonstrate any
differences in lactic acid production after the interven-
tion with either L. reuteri or L. rhamnosus GG. It could
be argued that the decreased acidogenity of the plaque
samples could be caused by the antibacterial activity of
L. reuteri, but due to the relatively short period of ad-
ministration we believe that this was not the case. Since
xylitol is not thought to be fermented by oral bacteria
[15] the low concentrations of LA after addition of xyli-
tol were expected. It should however be stressed that the
volunteers in this projects had healthy oral conditions
and most likely not fully representative for subjects with
an ecologically stressed and unbalanced biofilm. In the-
ory, such a condition could possibly increase the efficacy
of probiotic therapy. We and other research groups have
demonstrated that low pH conditions may promote
mutans streptococcus growth inhibition by probiotic
lactobacilli [16,17] and interfere with the biofilm forma-
tion [18]. Thus, further studies on selected caries-active
patients would be interesting. The conclusion so faraddition of L. plantarum 299v and L. reuteri DSM 17938 after
ensions without probiotic bacteria. The values shown are μg/mL after
Table 3 Mean lactic acid concentration (SD) μg/ml in
suspensions of pooled supragingival plaque from health
young adults (n=18)
Group BL FU
Fructose Xylitol Fructose Xylitol
Test 8.6 (5.4) 2.9 (2.0) 8.7 (4.7) 1.5 (3.5)
Placebo 9.5 (4.2) 3.2 (3.5) 10.8 (5.2) 2,9 (3.4)
Measurements made at baseline (BL) and follow-up (FU) after the two week
intervention period with L. reuteri (test) or placebo. Acid production was
initiated with either fructose or xylitol.
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acidogenic abilities, daily supplements of probiotic lacto-
bacilli did not seem to increase the acidogenity of the
dental plaque when exposed to fructose or xylitol.
There were no differences in salivary mutans strepto-
cocci levels between the two groups and we recorded no
changes after the intervention period. This was in con-
trast to several previous studies [2-5] but in concert with
others [9,19,20]. Differences in strains and bacterial con-
centrations, dose regimes and age groups used in the
earlier trials hamper any comparison between the trials
and thereby firm conclusions. It is generally believed
that probiotic supplements may be more effective in pre-
school ages than in adults [21], which to some extent
may explain our negative findings. The increased in
lactobacilli counts in the test group was logical and sup-
ported the findings of Marttinen and co-workers [13] al-
though we were not able to analyze whether or not it
was due to the specific strain tested. However, it is un-
likely that a permanent shift of the microbial compos-
ition occurs [22,23]. Caglar et al. [22] studied the
number of carriers of L. reuteri ATCC 55730 after a 2-
week intake period of tablets containing that strain.
Using selective media and analyzes for reuterin produc-
tion, the bacteria was recovered in all test subjects im-
mediately after the intervention period but it was
gradually eliminated within a few weeks. However, it is
still an open question if a colonization of the oral biofilm
per se is an absolute requirement for probiotic action.Conclusion
The results of the present study suggest that the acido-
genicity of suspension of dental plaque and probiotic
lactobacilli is strain-dependant and influenced by the
type of sugar available. Furthermore, The present study
provides no evidence of an increase in plaque acidity by
the supply of selected probiotic lactobacilli when chal-
lenged by fructose or xylitol.Competing interests
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